Your session is about to expire
← Back to Search
Exercise Training for Atrial Fibrillation
N/A
Waitlist Available
Led By Jennifer L Reed, PhD
Research Sponsored by Ottawa Heart Institute Research Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least 40 years of age
Persistent or permanent atrial fibrillation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
Study Summary
This trial will compare the effects of high-intensity interval training vs. moderate-intensity continuous exercise training in adults with persistent or permanent atrial fibrillation on exercise capacity and quality of life.
Who is the study for?
This trial is for adults over 40 with persistent or permanent atrial fibrillation, a resting heart rate of 110 bpm or less, and able to do an exercise test. They must not be already exercising regularly, have unstable angina, certain heart conditions like obstructive cardiomyopathy or severe valve stenosis, uncontrolled diabetes, and must agree to sign informed consent.Check my eligibility
What is being tested?
The study compares two types of exercise programs for people with atrial fibrillation: high-intensity interval training (short bursts of intense activity) versus moderate-intensity continuous training (steady activity). It aims to see which one better improves exercise capacity and quality of life.See study design
What are the potential side effects?
Exercise may cause shortness of breath, fatigue, muscle soreness or injury. High-intensity interval training can be more demanding on the heart; participants are monitored closely for any adverse effects related to their condition.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 40 years old or older.
Select...
I have ongoing or permanent irregular heartbeat.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in exercise capacity as measured by six-minute walk test distance
Change in quality of life as measured by the Short-Form 36 questionnaire
Secondary outcome measures
Change in activity status measured by the Duke Activity Status Index
Change in anxiety and depressive symptoms will be measured using the Hospital Anxiety and Depression Scale (HADS)
Change in disease specific quality of life will be measured using the University of Toronto Atrial Fibrillation Severity Scale (AFSS)
+9 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Moderate-intensity continuous exerciseExperimental Treatment1 Intervention
Moderate-intensity continuous exercise training
Group II: High-Intensity Interval TrainingExperimental Treatment1 Intervention
High-Intensity Interval Training
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
high-intensity interval training
2009
N/A
~270
Find a Location
Who is running the clinical trial?
Ottawa Heart Institute Research CorporationLead Sponsor
188 Previous Clinical Trials
92,342 Total Patients Enrolled
23 Trials studying Atrial Fibrillation
6,597 Patients Enrolled for Atrial Fibrillation
Jennifer L Reed, PhDPrincipal InvestigatorOttawa Heart Institute Research Corporation
6 Previous Clinical Trials
555 Total Patients Enrolled
4 Trials studying Atrial Fibrillation
380 Patients Enrolled for Atrial Fibrillation
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My diabetes is not well-managed.I am 40 years old or older.I have been diagnosed with severe narrowing of my heart's mitral or aortic valve.I have ongoing or permanent irregular heartbeat.I have been diagnosed with a thickened heart muscle that obstructs blood flow.I have unstable chest pain.You regularly exercise more than twice a week.You can do a test where you exercise until you feel a symptom.I agree to sign the informed consent.Your heart beats at a rate of 110 beats per minute or less when you are resting.
Research Study Groups:
This trial has the following groups:- Group 1: Moderate-intensity continuous exercise
- Group 2: High-Intensity Interval Training
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What are the main aims of this research endeavor?
"This 12-week study aims to appraise the quality of life through a Short-Form 36 questionnaire. Additionally, symptom severity and frequency shall be evaluated with the Canadian Cardiovascular Society Severity Scale and a 7-day Symptom Diary respectively. Lastly, muscular fitness will be evaluated by standard load tests."
Answered by AI
Is this experiment currently enrolling participants?
"Data found on clinicaltrials.gov suggests that this medical experiment is not accepting participants at the moment; although it was initiated November 1st 2015 and modified April 25th 2022, no new patients are being sought after. However, there are 476 other trials actively looking for volunteers to take part in them."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger